Early regression of left ventricular wall thickness following percutaneous aortic valve replacement with the CoreValve bioprosthesis

Journal of Invasive Cardiology

Volumn 21, Issue 4, 2009, Pages 151-155

  Jilaihawi, Hasan ^a   Jeilan, Mohamed ^a   Spyt, Tomasz ^a   Chin, Derek ^a   Logtens, Elaine ^a   Kovac, Jan ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Aortic stenosis; CoreValve; Left ventricular hypertrophy; Percutaneous aortic valve replacement

Indexed keywords

C REACTIVE PROTEIN;

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COREVALVE BIOPROSTHESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART VALVE BIOPROSTHESIS; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; PATIENT SAFETY; PERCUTANEOUS AORTA VALVE REPLACEMENT; REMISSION; AORTA VALVE; CARDIOMYOPATHY, HYPERTROPHIC; CLINICAL TRIAL; DISEASE COURSE; ECHOGRAPHY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VERY ELDERLY;

AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; AORTIC VALVE; C-REACTIVE PROTEIN; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649621692     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243.
2. Sasayama S, Ross J, Franklin D, et al. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976;38:172-178.
3. Eichorn P, Grimm J, Koch R, et al. Left ventricular relaxation in patients with left ventricular hypertrophy secondary to aortic valve disease. Circulation 1982;65:1395-1404.
4. Kuhl HP, Franke A, Puschmann D, et al. Regression of left ventricular mass one year after aortic valve replacement for pure severe aortic stenosis. Am J Cardiol 2002;89:408-413.
5. Ikonomidis I, Tsoukas A, Parthenakis F, et al. Four year follow up of aortic valve replacement for isolated aortic stenosis: A link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function. Heart 2001;86:309-316.
6. Renate E. Zybach-Benz, Beat C. et al. Impact of left ventricular hypertrophy late after aortic valve replacement for aortic stenosis on cardiovascular morbidity and mortality. Int J Cardiol 2006;109:41-47.
7. Kvidal P, Bergström R, Hörte L-G, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-756.
8. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 1999;15:816-822.
9. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve. J Am Coll Cardiol 2006;47:1214-1223.
10. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006;114:591-596.
11. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third- generation self-expanding CoreValve prosthesis. J Am Coll Cardiol 2007;50:69-76.
12. Jin XY, Zhang ZM, Gibson DG, et al. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg 1996;62:683-690.
13. De Paulis R, Sommariva L, Colagrande L, et al. Regression of left ventricular hypertrophy after aortic valve replacement for aortic stenosis with different valve substitutes. J Thorac Cardiovasc Surg 1998;116:590-598.
14. Jilaihawi H, Greaves S, Rouleau JL, et al. Healing and Early Afterload Reducing Therapy Trial Investigators. Left ventricular hypertrophy and the risk of subsequent left ventricular remodeling following myocardial infarction. Am J Cardiol 2003;91:723-726.
15. Devereux R, Reichek N. Echocardiographic assessment of left ventricular mass in man. Circulation 1977;55:613-618.
16. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-836.
17. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005;26:1790-1796.
18. Waszyrowski T, Kasprzak JD, Krzemińska-Pakula M, et al. Regression of left ventricular dilatation and hypertrophy after aortic valve replacement. Int J Car-diol 1996;57:217-225.
19. Lessick J, Mutlak D, Markiewicz W, Reisner SA. Failure of left ventricular hypertrophy to regress after surgery for aortic valve stenosis. Echocardiography 2002;19:359-366.
20. Dellgren G, Eriksson MJ, Blange I, et al. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol 1999;84:909-913.
21. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardio-graphically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
22. Lim E, Ayyaz A, Theodorou P, et al. Longitudinal study of the profile and predictors of left ventricular mass regression after stentless aortic valve replacement. Ann Thorac Surg 2008;85:2026-2029.
23. Monrad ES, Hess OM, Nonogi H, et al. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 1988;77;1345-1355.